A recent publication (May et al., 2019 ) introduced a novel means (i.e. WCT Formula) to automatically distinguish ventricular tachycardia and supraventricular wide complex tachycardia using modern-day computerized electrocardiogram software measurements. In this article, a summary of data components relating to the derivation and validation of the WCT Formula is presented. © 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/). Table 1 describes the clinical and ECG laboratory diagnosis data for the derivation cohort. Most (86.1%) clinical diagnoses were established by heart rhythm or non-heart rhythm cardiologists. A sizeable majority (91.8%) of WCTs were assigned definitive or probable interpretive diagnoses by the ECG laboratory. More than half of evaluated WCTs (51.4%) were derived from patients who underwent an electrophysiology procedure and/or possessed an implantable intra-cardiac device.
describes the clinical and ECG laboratory diagnosis data for the derivation cohort. Most (86.1%) clinical diagnoses were established by heart rhythm or non-heart rhythm cardiologists. A sizeable majority (91.8%) of WCTs were assigned definitive or probable interpretive diagnoses by the ECG laboratory. More than half of evaluated WCTs (51.4%) were derived from patients who underwent an electrophysiology procedure and/or possessed an implantable intra-cardiac device. Table 2 summarizes the patient characteristics of the derivation cohort. The SWCT group included fewer ECG pairs from patients with coronary artery disease, prior myocardial infarction, prior cardiac surgery, ongoing antiarrhythmic drug use, ischemic cardiomyopathy, non-ischemic cardiomyopathy, and implanted cardioverter-defibrillator. Baseline ECGs with ventricular pacing were more common in the VT group. Preexisting bundle branch block was more prevalent in the SWCT group. Table 3 describes the clinical and ECG laboratory diagnosis data for the validation cohort. Most (85.2%) clinical diagnoses were established by heart rhythm or non-heart rhythm cardiologists. Nearly all (98.2%) interpreted WCTs were assigned definitive or probable diagnoses by the ECG laboratory. A minority (31.0%) of evaluated WCTs were derived from patients who underwent an electrophysiology procedure. A sizable fraction (35.6%) of evaluated WCTs possessed an implantable intra-cardiac device. Table 4 summarizes the patient characteristics of the validation cohort. The VT group included more ECG pairs from patients with coronary artery disease, prior myocardial infarction, ongoing antiarrhythmic drug use, ischemic cardiomyopathy, and implanted cardioverter-defibrillator. The SWCT included more ECG pairs from patients with an implanted pacemaker lacking cardioverter-defibrillator capability. Baseline ECGs with ventricular pacing were more common in the VT group. Preexisting bundle branch block was more prevalent in the SWCT group. Table 6 provides a comparative summary of the patient characteristics for the derivation and validation cohorts. The derivation cohort included more ECG pairs from patients with severely reduced LVEF (<30%). The derivation cohort included more ECG pairs with a ventricular paced baseline heart rhythm. Table 7 summarizes the electrocardiographic characteristics of SWCTs erroneously classified as VT by the WCT Formula's 50% VT probability partition. Table 8 summarizes the electrocardiographic characteristics of VTs erroneously classified as SWCT by the WCT Formula's 50% VT probability partition. Fig. 1 summarizes the distribution of shared and non-shared WCT diagnoses between (1) the WCT Formula's 50% VT probability partition, (2) clinical diagnosis and (3) ECG laboratory interpretation. The WCT Formula's agreement with VT diagnoses established by either or both the ECG laboratory and clinical diagnosis was 91.4% and 85.3%, respectively. The WCT Formula's agreement with SWCT diagnoses established by either or both the ECG laboratory interpretation and clinical diagnosis was 93.5% and 86.9%, respectively.
Experimental design, materials, and methods
A recent study by May and colleagues details the development and validation of a logistic regression model capable of automatic VT probability estimation [1] . In a two-part investigation, a logistic regression model (i.e. WCT Formula) was derived and validated using two separate patient cohorts. In Part 1, a derivation cohort of paired WCT and subsequent baseline ECGs was examined to identify independent VT predictors to be incorporated into the WCT Formula. In Part 2, the WCT Formula's performance was prospectively evaluated against a validation cohort of paired WCT and subsequent baseline ECGs. The derivation cohort was comprised of 317 paired WCT (157 VT, 160 SWCT) and baseline ECGs. The validation cohort consisted of 284 paired WCT (116 VT, 168 SWCT) and baseline ECGs. The diagnostic performance of the WCT Formula was appraised according to its agreement with clinical and/or ECG laboratory diagnosis.
Paired WCT and subsequent baseline ECGs were acquired within clinical settings at the Mayo Clinic Rochester or Mayo Clinic Health System of South Eastern Minnesota between September 2011 and November 2016. Evaluated ECGs were standard, 12-lead recordings (paper speed: 25 mm/s, voltage calibration: 10 mm/mV) acquired from our institution's centralized ECG data archives (GE Healthcare; Milwaukee, WI). Data relating to clinical diagnosis, ECG laboratory interpretation and patient characteristics were recorded from the electronic medical record. Automated ECG measurements were accessed from GE Healthcare's MUSE ECG interpretation software. Novel computations, including frontal and horizontal percent amplitude change (PAC) (Fig. 2) , were calculated using automated measurements derived from paired WCT and subsequent baseline ECGs. 
